G Stephen DeCherney

MD, MPH. Professor of Medicine – Endocrinology/Metabolism – UNC


Stephen is board certified in Internal Medicine and Endocrinology, Diabetes, and Metabolism and was named one of the Best Doctors in America. Dr. DeCherney is also the Co-Founder & Chairman of Helios Clinical, a company that provides its biopharmaceutical partners high quality research and data. Earlier in his career, Stephen was the CEO& a board member of Health Decisions, Inc., a full service CRO specializing in clinical studies of therapeutics for women’s health. He also served as President, Global CRO at Quintiles Transnational Corporation and was an Independent Director of Theorem Clinical Research Company. Currently, Stephen serves on the Board of KNOW Bio, a subsidiary of Novan that develops and produces nitric oxide-based therapies, and the Board of Directors of Robert F. Kennedy Human Rights. He also serves as a Trustee of the University of Delaware Research Foundation and the Christiana Care Health System, and he is and he is a US Representative for the William Harvey Research Foundation, Queen Mary University, London. Previously, Stephen was a Board Member of Symyx Corporation, also serving on their Audit Committee. He was a senior advisor to the London Genetics Company, Member of the Farmer Food Share Board of Trustees and Chairman of their Finance Subcommittee. DeCherney received a B.A. in Biology from Columbia College. He was awarded the Columbia College Alumni Achievement Award granted to the “Senior Adjudged Most Outstanding in Qualities of Mind, Character, and Service to the College.” He received his medical degree from Temple University in Philadelphia and completed his internal medicine residency at the Graduate Hospital of the University of Pennsylvania. DeCherney received his endocrinology training at Vanderbilt University and a master’s in public health from Columbia.